Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry

BACKGROUND: Data on the use of the wearable cardioverter‐defibrillator (WCD) among patients with myocarditis remain sparse. Consequently, evidence for guideline recommendations in this patient population is lacking. METHODS AND RESULTS: In total, 1596 consecutive patients were included in a multicen...

Descripción completa

Detalles Bibliográficos
Autores principales: El‐Battrawy, Ibrahim, Koepsel, Katharina, Tenbrink, David, Kovacs, Boldizsar, Dreher, Tobias C., Blockhaus, Christian, Gotzmann, Michael, Klein, Norbert, Kuntz, Thomas, Shin, Dong‐In, Lapp, Hendrik, Rosenkaimer, Stephanie, Abumayyaleh, Mohammad, Hamdani, Nazha, Saguner, Ardan Muammer, Kowitz, Jacqueline, Erath, Julia W., Duru, Firat, Mügge, Andreas, Akin, Ibrahim, Aweimer, Assem, Beiert, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547297/
https://www.ncbi.nlm.nih.gov/pubmed/37681569
http://dx.doi.org/10.1161/JAHA.123.030615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547297/
https://www.ncbi.nlm.nih.gov/pubmed/37681569
http://dx.doi.org/10.1161/JAHA.123.030615

Ejemplares similares